INTRODUCTIONA malignant pleural effusion (MPE) is defined by an increase in the volume of pleural fluid accompanied by the presence of malignant cells. MPE may develop because of a primary pleural malignancy, for example mesothelioma, but more commonly occurs following metastatic cancer. The number of new patients diagnosed with MPE diagnosed in Europe each year is over 100 000, with lung cancer being the most common underlying aetiology (accounting for approximately one‐third of all cases). Other secondary malignancies that may cause MPE include breast cancer, lymphoma, ovarian cancer, colon cancer and other solid tumours. Because pleural involvement generally reflects the presence of advanced‐stage tumours, the treatment for MPE is aimed to prevent recurrences by obliterating the pleural cavity; this can be achieved by introducing a sclerosing agent into the pleural space (pleurodesis). It is expected that approximately 60% of patients with MPE will require pleurodesis to prevent fluid reaccumulation, especially in the presence of large and/or recurrent pleural effusions. Owing to its good safety profile, talc remains the most commonly used sclerosing agent for recurrent MPE. Specifically, calibrated talc has gained popularity for chemical pleurodesis. The mechanisms of talc‐induced artificial obliteration of the pleural space include the induction of
European Journal of Clinical Investigation – Wiley
Published: Jan 1, 2018
Keywords: ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera